Address: 1172 Castro Street, Moutain View, California 94040-2552, USA
Phone: +001-(650)-934-5200 | Fax: +001-(650)-934-5389 | Map/Directions >>

Profile: VIVUS Inc. is a drug-development company dedicated to the development & commercialization of next-generation therapeutic products addressing obesity and sexual health. Our pipeline includes products in late-stage clinical development addressing obesity and sexual health. We currently have four mid-to-late-stage clinical development programs in progress that target obesity, diabetes, and sexual health. Our Qnexa™ is a proprietary therapeutic formulation & dosing regimen that incorporates the active ingredients from phentermine and topiramate that demonstrate weight loss properties. It simultaneously addresses appetite and satiety, the two main mechanisms that impact eating behavior. Our Avanafil is a specific, highly-selective phosphodiesterase type 5 (PDE5) inhibitor, oral medication under investigation for the treatment of erectile dysfunction (ED).

The company was founded in 1991, has revenues of USD 25-50 Million, has ~40 employees and is ISO 9001 certified. NASDAQ:VVUS (SEC Filings)

3 Products/Services (Click for related suppliers)  
• Erectile Dysfunction Device (FDA Code: LST)
• Non-invasive Drug Delivery System
• Suppositories & Inserts

 Edit or Enhance this Company (461 potential buyers viewed listing,  49 forwarded to manufacturer's website)
Browse Category   |   Alphabetical Products   |   ALL 25,000 Suppliers
HomeBuyAdd FREE ListingAdvertise Medical CompanyMedical Portal